Breast Ultrasound Market Set to Reach USD 6.85 Billion by 2031

The Global Breast Ultrasound Market is on a strong upward trajectory, with projections indicating it will reach a value of US$ 6.85 billion by 2031, expanding at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2025 to 2031. According to a comprehensive market analysis by The Insight Partners, this growth is being propelled by a combination of rising disease prevalence, aging populations, technological innovation, and supportive government policies.

A Market Driven by Rising Breast Cancer Rates

One of the most significant forces shaping the breast ultrasound market is the increasing global incidence of breast cancer. The World Health Organization identifies breast cancer as the most prevalent cancer in the world, with approximately 1 in 8 women expected to receive a diagnosis during their lifetime. As awareness campaigns and routine screening programs expand, detection rates continue to climb — driving demand for advanced imaging tools like ultrasound. Unlike mammography alone, breast ultrasound serves as a critical complementary tool, particularly for women with dense breast tissue, offering clinicians a clearer and more detailed view of potential abnormalities.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006834

Aging Populations Amplifying Demand

The global rise in the geriatric population is another major contributor to market growth. Breast cancer diagnoses are most common around the median age of 62, which means that as life expectancy increases worldwide, the number of women at elevated risk continues to grow. Healthcare systems across North America, Europe, and Asia-Pacific are adapting their screening infrastructure to meet this demographic shift, spurring demand for reliable and accessible breast imaging technologies.

Government Initiatives and Regulatory Support

Regulatory frameworks are playing an important role in sustaining market growth. In the United States, the Mammography Quality Standards Act (MQSA) mandates that mammography facilities meet specific standards for quality and certification, ensuring that women have access to consistent and accurate breast cancer screenings. Such government-backed initiatives not only improve public health outcomes but also create a stable environment for market expansion, encouraging healthcare providers to invest in advanced ultrasound equipment.

Technological Advancements Reshaping the Landscape

Innovation is at the heart of the breast ultrasound market's evolution. The development of higher-resolution imaging systems and three-dimensional (3D) ultrasound technologies is enhancing diagnostic precision, allowing clinicians to detect lesions that might previously have gone unnoticed. Additionally, the rise of Automated Breast Ultrasound (ABUS) is complementing traditional Conventional Breast Ultrasound (CBUS), offering more standardized and reproducible results across different clinical settings.

The expansion of point-of-care ultrasound is also reshaping how and where breast imaging is delivered. By enabling scans in primary care and outpatient clinic settings — not just specialist centers — point-of-care solutions are making breast health services more accessible to a broader patient population, especially in underserved regions.

AI Integration: A Game-Changer on the Horizon

Among the most exciting opportunities in the breast ultrasound market is the integration of artificial intelligence. AI-powered algorithms are showing strong potential in assisting radiologists with image interpretation, improving diagnostic accuracy, and significantly reducing the time required for analysis. As AI tools become more sophisticated and clinically validated, their adoption within breast imaging workflows is expected to accelerate, creating new avenues for market growth and improved patient outcomes.

Market Segmentation and Regional Insights

The market is segmented by product type — Conventional Breast Ultrasound and Automated Breast Ultrasound — and by end user, including hospitals, diagnostic imaging laboratories, and others. North America held the largest regional share in 2023, with the United States leading the way, driven by its advanced healthcare infrastructure and strong adoption of screening programs. Hospitals represent the dominant end-user segment, reflecting their central role in delivering imaging services.

Key players operating in this market include General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Hologic, Inc., Canon Medical Systems Corporation, and Hitachi, Ltd., among others.

Conclusion

The breast ultrasound market stands at a pivotal moment, with powerful demographic, technological, and policy-driven forces aligning to support sustained growth through 2031. As AI integration deepens and imaging technology continues to evolve, breast ultrasound is poised to become an even more indispensable tool in the global fight against breast cancer.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.